MICA-129Met homozygosity confers susceptibility to inflammatory bowel disease (78), while MICA-129Val homozygosity leads to faster progression of multiple myeloma (MM) (79) and also plays a role in susceptibility for breast cancer development (80). The gene discussed is MICA; the disease is plasma cell myeloma.